Skip to main content

Hypertensive Disorders of Pregnancy clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

    Sorry, not yet accepting patients

    The overall goal of this large, pragmatic, comparative effectiveness trial is to test the hypothesis that among at-risk individuals, 162 mg/day aspirin is superior to 81 mg/day in preventing Hypertensive disorders of pregnancy (HDP), and that there are multiple factors associated with adherence with aspirin therapy that will be important to identify to enable optimal implementation of study findings and population-level benefits.

    San Francisco, California and other locations

Our lead scientists for Hypertensive Disorders of Pregnancy research studies include .

Last updated: